Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial

被引：0
|
作者：
Nicholas L. Syn
Andrea Li-Ann Wong
Soo-Chin Lee
Hock-Luen Teoh
James Wei Luen Yip
Raymond CS Seet
Wee Tiong Yeo
William Kristanto
Ping-Chong Bee
LM Poon
Patrick Marban
Tuck Seng Wu
Michael D. Winther
Liam R. Brunham
Richie Soong
Bee-Choo Tai
Boon-Cher Goh
机构：
[1] National University Cancer Institute,Department of Haematology
[2] National University of Singapore,Oncology
[3] National University Health System,Cancer Science Institute of Singapore
[4] National University Heart Centre,Division of Neurology, Department of Medicine
[5] University of Malaya Medical Centre,Department of Cardiology
[6] National University Hospital,Department of Medicine
[7] Genome Institute of Singapore,Department of Pharmacy
[8] Agency for Science,Department of Medicine, Centre for Heart Lung Innovation
[9] Technology and Research,Department of Pathology
[10] Translational Laboratory in Genetic Medicine,Saw Swee Hock School of Public Health
[11] Agency for Science,Department of Pharmacology
[12] Technology and Research,Department of Medicine
[13] University of British Columbia,undefined
[14] Yong Loo Lin School of Medicine,undefined
[15] National University Health System,undefined
[16] National University of Singapore,undefined
[17] Yong Loo Lin School of Medicine,undefined
[18] National University Health System,undefined
[19] Yong Loo Lin School of Medicine,undefined
[20] National University of Singapore,undefined
来源：
BMC Medicine | / 16卷
关键词：
Pharmacogenetics; Pharmacogenomics; Precision medicine; CYP2C9; Cytochrome P450; VKORC1; Warfarin; Anticoagulants; Anticoagulation; Polymorphism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] SLCO1B1 Genotype-Guided Statin Therapy Lowers LDL Cholesterol in Patients With Statin-Intolerance-A Randomized Controlled Trial
    Voora, Deepak
    Perry, Emily
    Singh, Kavisha
    Trujillo, Gloria
    Milazzo, Nicholas
    Savard, Dillon
    Haga, Susanne
    Musty, Michael D.
    Li, Yi-Ju
    Peyser, Bruce
    CIRCULATION, 2016, 134
  • [42] A randomized trial of initial warfarin dosing based on simple clinical criteria
    Shine, D
    Patel, J
    Kumar, J
    Malik, A
    Jaeger, J
    Maida, M
    Ord, L
    Burrows, G
    THROMBOSIS AND HAEMOSTASIS, 2003, 89 (02) : 297 - 304
  • [43] Cost-Effectiveness Analysis of Pharmacogenomics-Guided Versus Standard Dosing of Warfarin in Patients with Mechanical Prosthetic
    Hemati, Homa
    Nosrati, Marzieh
    Hasanzad, Mandana
    Rahmani, Parham
    Fariman, Soroush
    Sarabi, Mohadese
    Shirvani, Sepideh
    Sadeghipour, Parham
    Nikfar, Shekoufeh
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2024, 23 (01):
  • [44] UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients
    Hulshof, Emma C.
    de With, Mirjam
    de Man, Femke M.
    Creemers, Geert-Jan
    Deiman, Birgit A. L. M.
    Swen, Jesse J.
    Houterman, Saskia
    Koolen, Stijn L. W.
    Bins, Sander
    Thijs, Anna M. J.
    Laven, Marjan M. J.
    Hovels, Anke M.
    Luelmo, Saskia A. C.
    Houtsma, Danny
    Shulman, Katerina
    McLeod, Howard L.
    van Schaik, Ron H. N.
    Guchelaar, Henk-Jan
    Mathijssen, Ron H. J.
    Gelderblom, Hans
    Deenen, Maarten J.
    EUROPEAN JOURNAL OF CANCER, 2022, 162 : 148 - 157
  • [45] Clinical Application of Pharmacogenetic-Based Warfarin-Dosing Algorithm in Patients of Han Nationality after Rheumatic Valve Replacement: A Randomized and Controlled Trial
    Wang, MingSong
    Lang, XiLong
    Cui, ShiTao
    Fei, Ke
    Zou, LiangJian
    Cao, Jia
    Wang, LiangXu
    Zhang, ShengHui
    Wu, XinTian
    Wang, YiLing
    Ji, Qiang
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2012, 9 (06): : 472 - 479
  • [46] Clinical benefits of pharmacogenetic algorithm-based warfarin dosing: meta-analysis of randomized controlled trials
    Li, Xiaoqi
    Yang, Jie
    Wang, Xuyun
    Xu, Qiang
    Zhang, Yuxiao
    Yin, Tong
    THROMBOSIS RESEARCH, 2015, 135 (04) : 621 - 629
  • [47] Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design
    van Schie, Rianne M. F.
    Wadelius, Mia
    Kamali, Farhad
    Daly, Ann K.
    Manolopoulos, Vangelis G.
    de Boer, Anthonius
    Barallon, Rita
    Verhoef, Talitha I.
    Kirchheiner, Julia
    Haschke-Becher, Elisabeth
    Briz, Montserrat
    Rosendaal, Frits R.
    Redekop, William K.
    Pirmohamed, Munir
    Maitland-van der Zee, Anke-Hilse
    PHARMACOGENOMICS, 2009, 10 (10) : 1687 - 1695
  • [48] Exposure to Non-Therapeutic INR in a High Risk Cardiovascular Patient: Potential Hazard Reduction with Genotype-guided Warfarin (Coumadin®) Dosing
    Rodriguez-Velez, Rosangela
    Ortiz-Rivera, Oscar J.
    Bower, Bruce
    Gorowski, Krystyna
    Windemuth, Andreas
    Villagra, David
    Kocherla, Mohan
    Seip, Richard L.
    D'Agostino, Darrin
    Vergara, Cunegundo
    Ruano, Gualberto
    Duconge, Jorge
    PUERTO RICO HEALTH SCIENCES JOURNAL, 2010, 29 (04) : 402 - 408
  • [49] A Randomized and Clinical Effectiveness Trial Comparing Two Pharmacogenetic Algorithms and Standard Care for Individualizing Warfarin Dosing (CoumaGen-II)
    Anderson, Jeffrey L.
    Horne, Benjamin D.
    Stevens, Scott M.
    Woller, Scott C.
    Samuelson, Kent M.
    Mansfield, Justin W.
    Robinson, Michelle
    Barton, Stephanie
    Brunisholz, Kim
    Mower, Chrissa P.
    Huntinghouse, John A.
    Rollo, Jeffrey S.
    Siler, Dustin
    Bair, Tami L.
    Knight, Stacey
    Muhlestein, Joseph B.
    Carlquist, John F.
    CIRCULATION, 2012, 125 (16) : 1997 - +
  • [50] Cluster randomized controlled trial of a simple warfarin maintenance dosing algorithm versus usual care among primary care practices
    Nieuwlaat, Robby
    Eikelboom, John W.
    Schulman, Sam
    van Spall, Harriette G. C.
    Schulze, Karleen M.
    Connolly, Benjamin J.
    Cuddy, Spencer M.
    Hubers, Lowiek M.
    Stehouwer, Alexander C.
    Connolly, Stuart J.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2014, 37 (04) : 435 - 442
12345